NTV Asset Management LLC lifted its holdings in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 2.9% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 64,046 shares of the financial services provider’s stock after buying an additional 1,813 shares during the period. iShares Nasdaq Biotechnology ETF comprises about 2.1% of NTV Asset Management LLC’s portfolio, making the stock its 7th biggest holding. NTV Asset Management LLC owned about 0.08% of iShares Nasdaq Biotechnology ETF worth $7,810,000 at the end of the most recent quarter.
Several other institutional investors have also bought and sold shares of IBB. Paloma Partners Management Co increased its holdings in iShares Nasdaq Biotechnology ETF by 1,643.3% in the 2nd quarter. Paloma Partners Management Co now owns 323,373 shares of the financial services provider’s stock worth $35,513,000 after purchasing an additional 304,824 shares in the last quarter. Commerzbank Aktiengesellschaft FI grew its position in shares of iShares Nasdaq Biotechnology ETF by 54.0% in the 2nd quarter. Commerzbank Aktiengesellschaft FI now owns 585,506 shares of the financial services provider’s stock valued at $64,300,000 after buying an additional 205,200 shares during the last quarter. Raymond James Financial Services Advisors Inc. bought a new stake in shares of iShares Nasdaq Biotechnology ETF in the 2nd quarter valued at about $18,741,000. Cornerstone Wealth Management LLC bought a new stake in shares of iShares Nasdaq Biotechnology ETF in the 2nd quarter valued at about $1,420,000. Finally, Aviance Capital Management LLC grew its position in shares of iShares Nasdaq Biotechnology ETF by 730.2% in the 3rd quarter. Aviance Capital Management LLC now owns 147,849 shares of the financial services provider’s stock valued at $18,029,000 after buying an additional 130,040 shares during the last quarter. 63.65% of the stock is owned by institutional investors.
Shares of iShares Nasdaq Biotechnology ETF stock traded down $3.24 on Friday, hitting $103.64. 2,011,005 shares of the company’s stock traded hands, compared to its average volume of 1,748,692. iShares Nasdaq Biotechnology ETF has a one year low of $100.22 and a one year high of $122.97.
WARNING: “NTV Asset Management LLC Purchases 1,813 Shares of iShares Nasdaq Biotechnology ETF (IBB)” was first reported by Fairfield Current and is the sole property of of Fairfield Current. If you are reading this report on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this report can be read at https://www.fairfieldcurrent.com/news/2018/12/08/ishares-nasdaq-biotechnology-etf-ibb-is-ntv-asset-management-llcs-7th-largest-position.html.
iShares Nasdaq Biotechnology ETF Company Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Featured Article: 52-Week High/Low Prices For Stock Selection
Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com’s FREE daily email newsletter.